Summary
Generic semaglutide is Health Canada-approved, but provincial drug plan coverage varies significantly. Most provinces cover semaglutide for Type 2 diabetes — and are actively updating formularies to include the generics. Coverage for weight loss only is generally not available under any provincial plan. This page tracks the current status for each province.
How Provincial Generic Drug Coverage Works
When Health Canada approves a generic drug, it enters the provincial formulary process. Each province's drug benefit program negotiates pricing through the pan-Canadian Pharmaceutical Alliance (pCPA), then lists the drug under specific conditions. For semaglutide, the existing condition on all provincial formularies is Type 2 diabetes — the same as for brand-name Ozempic. Generics are typically listed faster than brand-name drugs because they come in at a lower price point and face less Patented Medicine Prices Review Board scrutiny. However, 'faster' still means weeks to months, not days. Provinces with the most active formulary update processes (Ontario, BC, Alberta) are expected to list generic semaglutide within 30–60 days of the May 2026 approval. Smaller provinces may take longer. The critical point: if semaglutide is already covered in your province for T2D under Ozempic, the generic will almost certainly be covered under the same criteria — and at a lower copay.
Key point: Provinces that already cover Ozempic for T2D will cover generic semaglutide. The only question is timing — most are updating formularies now.
Province-by-Province Coverage Status
**Ontario (ODB — Ontario Drug Benefit Program)**
Ozempic is listed on the ODB formulary for Type 2 diabetes with a Limited Use code (LU). Generic semaglutide is expected to be added to the ODB formulary within 30–60 days of the May 2026 approval. Once listed, patient copay will be the standard ODB copay: $2/prescription for recipients on OW/ODSP, $6.11 for seniors on OAS/GIS. Patients who currently receive Ozempic through ODB can ask their pharmacist to switch to the generic when listed — same LU code applies. For patients not on ODB (private insurance only), check your benefits plan directly.
**British Columbia (BC PharmaCare)**
BC PharmaCare covers semaglutide under Special Authority for T2D patients who meet specific criteria (failure on metformin and other agents). Generic semaglutide will require a new Special Authority application once listed on the BC formulary. BC PharmaCare typically processes generic additions within 60–90 days of Health Canada approval. Patient cost after coverage: $0 for PharmaCare Plan B (low-income), income-based deductible for Plan C/D.
**Alberta (Supplemental Health Benefits / NIHB)**
Alberta's provincial drug benefit covers semaglutide for T2D patients under Supplemental Health Benefits. The Non-Insured Health Benefits (NIHB) program for First Nations also covers semaglutide with a prior authorization process. Generic semaglutide formulary addition expected within 60 days. Contact AHS Drug Benefit Programs directly to confirm current status.
**Quebec (RAMQ)**
Régie de l'assurance maladie du Québec covers semaglutide for T2D under its drug plan. RAMQ typically adds generics to its formulary 3–6 months after Health Canada approval. Generic semaglutide is expected to appear on the RAMQ formulary by Q3 2026. Until then, patients paying out of pocket in Quebec will find generics available at pharmacy without plan coverage.
**Manitoba (Manitoba Pharmacare)**
Manitoba Pharmacare covers semaglutide for T2D on its formulary. Generic inclusion is expected within 60–90 days. Patient deductible is income-based under Manitoba's Pharmacare Deductible program — those with lower income may have minimal or no copay.
**Saskatchewan (Saskatchewan Drug Plan)**
Saskatchewan lists semaglutide under its Exceptional Drug Status program for T2D. Generic semaglutide will need to go through the same Exceptional Drug Status process. This may take 90–120 days longer than other provinces due to the additional review step.
**Nova Scotia, New Brunswick, PEI, Newfoundland & Labrador**
Atlantic provinces generally follow the pCPA framework and update formularies within 90–120 days of Health Canada approval. Semaglutide is covered for T2D in most Atlantic provinces — check your specific provincial plan for generic listing status.
**Territories (Yukon, NWT, Nunavut)**
First Nations and Inuit residents in the territories are covered under the federal NIHB program, which covers semaglutide for T2D with prior authorization. Territorial health programs are smaller and may have longer formulary update cycles — contact your territorial health authority for current status.
What to Do If Your Province Hasn't Listed Generic Semaglutide Yet
You have three options while waiting for your provincial formulary to update: (1) **Pay out of pocket temporarily**: At $114–150/month, generic semaglutide is significantly cheaper than the $250–500 you'd pay for brand-name Ozempic. Some patients find it's worth paying the lower out-of-pocket price for 1–2 months while coverage is being added. (2) **Continue with brand-name Ozempic** if it's already covered under your current plan: Your coverage for Ozempic doesn't stop when the generic is approved. You can stay on Ozempic until the generic is listed on your plan, then switch. (3) **Ask your pharmacist to submit a Special Authorization or Prior Approval request** for the generic under your current drug plan: pharmacists and physicians have expedited pathways for situations like this. In some cases, your doctor can request the generic be approved on a case-by-case basis while the formulary update is pending.
Key point: If your province hasn't listed the generic yet, staying on Ozempic (if covered) or paying $114/mo out of pocket for the generic are both reasonable short-term options.
Coverage for Weight Loss: All Provinces
No provincial drug plan currently covers semaglutide — brand-name or generic — for weight loss alone. Coverage requires a Type 2 diabetes diagnosis and typically requires documented failure on first-line diabetes medications (usually metformin). If your goal is weight loss without a T2D diagnosis, your options are: (1) Private insurance, if your employer plan covers obesity treatment — call your benefits provider and ask specifically about GLP-1 medications for obesity; (2) Out-of-pocket payment: $114–150/month for generic semaglutide is the current out-of-pocket cost; (3) Telehealth programs like Hims & Hers Canada or Felix Health that bundle the consultation and prescription into an all-in monthly fee. Obesity Canada is actively advocating for provinces to add obesity treatment coverage — some provincial plans (Alberta, Ontario) have signaled openness to expanding coverage. This may change in 2026–2027.
🍁 What This Means for Canadians
Canada's decentralized drug coverage system means that Health Canada approval is only the first step. The pan-Canadian Pharmaceutical Alliance (pCPA) negotiates pricing with manufacturers on behalf of all provinces, then each province decides whether and how to list a drug on their formulary. For generics, the process is typically faster because the pCPA framework has pre-negotiated pricing rules (generics must be listed at a lower price than the brand-name reference product). The May 2026 approval of two semaglutide generics triggered automatic pricing reviews in all provinces with Ozempic already listed.
See Current Generic Semaglutide Prices Across Canada
Our Generic Semaglutide Tracker shows the latest pharmacy pricing and formulary updates — so you always know what you'll pay, whether covered or out of pocket.
Information on this page is for general informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making any healthcare decisions.